EULAV Asset Management 13F: New $3.2M Stake in THC
Key Points
- EULAV Asset Management's new position in Tenet Healthcare represents about 0.3% of its total reported value of $1.06 billion.
- EULAV Asset Management held 12,444 $THC shares at quarter end, all of it a new position.
- Tenet Healthcare shares recently traded around $268.95, which is about equal to the $268.45 closing price on the filing date.
- Analysts maintain a positive outlook on Tenet Healthcare, with a mean price target of $286.41, indicating potential upside from current levels.
Since the filing, $THC is up 0.2% to date (from the $268.45 close on Oct 23, 2026).
Get Tenet Healthcare text alerts
We text you when insiders, Congress, analysts or big funds move on $THC.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Tenet Healthcare Corporation alert may contain errors. Disclosures
EULAV Asset Management took a new position in Tenet Healthcare Corporation (NYSE: THC) by acquiring 12,444 shares valued at approximately $3.18 million in a filing on October 23, 2026. This marks the fund's first investment in Tenet, as it had no prior shares in the company.
THC
Tenet Healthcare Corporation
EULAV Asset Management vs. the S&P 500
Hypothetical returns from EULAV Asset Management's disclosed trades, not real profit or advice. How we model this.
Where Tenet Healthcare Fits in EULAV Asset Management's Portfolio
EULAV Asset Management's investment in Tenet Healthcare represents about 0.3% of its total reported value of $1.06 billion, ranking it 35th among the fund's 151 positions. This new stake indicates a strategic entry into the healthcare sector, which has shown resilience and growth potential.
Other Institutional Activity in Tenet Healthcare
Other institutional investors have also shown interest in Tenet Healthcare. Boston Partners owns 4,433,360 shares worth about $1.19 billion, having increased its stake by 598,273 shares. Lone Pine Capital holds 2,258,717 shares valued at approximately $422.6 million, with a recent increase of 471,391 shares. Farallon Capital Management has 452,153 shares worth about $84.6 million, up by 80,000 shares.
Tenet Healthcare Corporation Stock Down 0.6%
Tenet Healthcare shares recently traded around $268.95, which is about equal to the $268.45 closing price on October 23, 2026. The stock is currently above its 50-day moving average of $264.88 and well above its 52-week low of $157.58, reflecting strong recent performance. However, it remains below its 52-week high of $283.05.
Recent Earnings
Tenet Healthcare reported trailing twelve-month revenue of approximately $21.81 billion, with a year-over-year revenue growth of 6.8%. The company's earnings per share (EPS) for the same period were $26.02, highlighting its profitability in the competitive healthcare market. The next earnings report is scheduled for October 29, 2026.
Analysts Set New Price Targets
Analysts are optimistic about Tenet Healthcare's future performance. On October 16, 2026, Guggenheim maintained a Buy rating with a price target of $307. Earlier, Truist Securities and Wells Fargo reaffirmed their Buy and Overweight ratings with targets of $290 and $281, respectively. The consensus target price among analysts stands at $286.41, indicating potential upside from current trading levels.
About Tenet Healthcare
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. It runs general hospitals that provide acute care services alongside ambulatory care facilities. The company's broad range of services positions it well in the healthcare sector, which continues to evolve and expand.
Bottom Line
EULAV Asset Management's new stake in Tenet Healthcare reflects growing institutional interest in the healthcare sector. Investors should watch for the company's upcoming earnings report on October 29, 2026, to gain further insights into its financial health and performance. As always, monitor future filings for any changes in insider or institutional holdings.
Related Filing Alerts
Source: EULAV Asset Management's 13F filing on $THC (Oct 23, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Written by software, not financial advice. How we make alerts